Prolacta Bioscience
Venture Round in 2016
Prolacta Bioscience Inc. is a life science company based in Duarte, California, specializing in the development and production of human milk-based nutritional products for premature and critically ill infants in neonatal intensive care units (NICUs). Established in 1999, Prolacta is recognized for its innovative approach, being the first and only company to offer a human milk fortifier made entirely from human milk. The company's product line includes human milk fortifiers, caloric fortifiers, standardized human milk, and ready-to-feed formulas specifically designed to meet the unique nutritional needs of vulnerable infants. Prolacta operates a pharmaceutical-grade processing facility that employs patented methods to ensure the safety and quality of its products. By focusing on advancing the science of human milk, Prolacta aims to significantly improve the health outcomes of critically ill infants through its specialized formulations and commitment to research.
Prolacta Bioscience
Series D in 2011
Prolacta Bioscience Inc. is a life science company based in Duarte, California, specializing in the development and production of human milk-based nutritional products for premature and critically ill infants in neonatal intensive care units (NICUs). Established in 1999, Prolacta is recognized for its innovative approach, being the first and only company to offer a human milk fortifier made entirely from human milk. The company's product line includes human milk fortifiers, caloric fortifiers, standardized human milk, and ready-to-feed formulas specifically designed to meet the unique nutritional needs of vulnerable infants. Prolacta operates a pharmaceutical-grade processing facility that employs patented methods to ensure the safety and quality of its products. By focusing on advancing the science of human milk, Prolacta aims to significantly improve the health outcomes of critically ill infants through its specialized formulations and commitment to research.
CambridgeSoft
Venture Round in 2009
CambridgeSoft Corporation is a prominent provider of software and solutions tailored for the pharmaceutical, biotechnology, and chemical industries. The company specializes in offering enterprise solutions, desktop software, scientific databases, and consulting services that facilitate the discovery and collaboration of scientific knowledge. Its flagship product, Chem & Bio Office, serves as a critical communication tool for chemists, allowing them to effectively create, analyze, and share chemical and biological information. Additionally, the enterprise version, Chem & Bio Office Enterprise, supports organizations in deploying comprehensive research information solutions through various digital technologies. CambridgeSoft's products are widely utilized across the pharmaceutical and biotechnology sectors, as well as in academic and government research settings, enhancing the efficiency and effectiveness of scientific communication and discovery processes.
Foundation Radiology Group
Series A in 2009
Foundation Radiology, Inc. is a diagnostic imaging services company based in Pittsburgh, Pennsylvania, that offers comprehensive radiology solutions to hospitals, referring physicians, radiology groups, and patients primarily in the Northeast, Eastern Midwest, and East Coast regions of the United States. Founded in 2006 and formerly known as Teleradiology Holdings, Inc., the company provides a wide range of services, including pediatrics, women's imaging, neuroradiology, and emergency radiology, along with advanced techniques like coronary CT angiography and virtual colonoscopy. Foundation Radiology operates both on-site and teleradiology services, ensuring 24/7 availability to meet the needs of healthcare providers and enhance patient care. The company aims to improve radiology practice in community healthcare settings through innovative solutions and continuous workflow improvements.